Is reserpine a human teratogen?
AUTOR(ES)
Pauli, R M
RESUMO
A single stillborn female with craniofacial, abdominal, and central nervous system malformations was exposed to reserpine during the first six weeks of gestation. Parallels between the malformations present in this infant and those induced in rats through exposure to reserpine at analogous periods of gestation suggest that reserpine may pose specific risks for malformations in some pregnancies.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1049642Documentos Relacionados
- Reserpine is not a human teratogen.
- Reserpine and ajmaline
- Teratogen Update: Environmentally Induced Birth Defect Risks
- Reserpine methonitrate, a novel quaternary analogue of reserpine augments urinary excretion of VMA and 5-HIAA without affecting HVA in rats
- Expression cloning of a reserpine-sensitive vesicular monoamine transporter.
